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M A J O R A R T I C L E
Differential Changes in Expression of Intestinal
Antimicrobial Peptide Genes During Ascaris
lumbricoides Infection in Zambian Adults Do Not
Respond to Helminth Eradication
Melissa C. Kapulu,1,a Michelo Simuyandi,2 Sandie Sianongo,2 Mubanga Mutale,2 Max Katubulushi,2 and Paul Kelly2,3
1Biological Sciences Department, School of Natural Sciences, and 2Tropical Gastroenterology and Nutrition Group, Department of Medicine, School of
Medicine, University of Zambia, Lusaka; and 3Blizard Institute of Cell and Molecular Science, Barts & The London School of Medicine, Queen Mary
University of London, United Kingdom
Background. Intestinal helminthiasis modulates immune responses to vaccines and environmental allergens.
To explore the impact on intestinal host defense, we assessed expression of antimicrobial peptide genes, together
with T cell subset markers and cytokines, in patients with ascariasis before and after treatment.
Methods. Case patients (n5 27) and control subjects (n5 44) underwent enteroscopy for collection of jejunal
biopsy specimens, which were used in quantitative, real-time reverse-transcription polymerase chain reaction for
a range of host defense genes; blood samples were also analyzed simultaneously.
Results. The level of gene expression (mRNA) of HD5, hBD1, and LL-37 was lower in case patients than
in control subjects, and the level of expression of HD6 was increased. However, after successful eradication, there
was no trend to values seen in control subjects. Helminthiasis was associated with increased intestinal expression
of the Th1 genes T-bet and interferon-c. In peripheral blood mononuclear cells (PBMCs), a mixed profile of T
cell markers and cytokines was increased. Ascaris-induced down-regulation of HD5 was observed in individuals
with higher RORct expression in PBMCs, but we found no evidence that this was mediated by circulating
interleukin-22.
Conclusions. Human ascariasis was associated with changes in antimicrobial peptide gene expression and
immunological markers. Such changes may have implications for susceptibility to infectious disease and
responsiveness to oral vaccines in tropical populations.
Helminth infections are common infectious diseases in
tropical countries, where millions are infected with
Ascaris species, hookworms, Schistosoma species, and
Taenia species parasites [1]. Most infections have
modest clinical significance, but there are probably ef-
fects on growth and development in children and
on work capacity and well-being in adults. Some
individuals with severe infections develop serious con-
sequences [1, 2]. There is emerging evidence that
immune dysregulation consequent upon helminth in-
fection may alter responses to certain vaccines as well as
to other infections [2–7]. Paradoxically, populations not
exposed to the immunological effects of helminth in-
fection may also be at risk of disease, including chronic
inflammatory conditions, such as Crohn disease,
ulcerative colitis, and asthma. There is some evidence
that these disorders can be treated by reimposition of
the immunological restraints on inflammation that
helminth infections confer [8–10].
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In animal models—notably, murine infection models of
Trichuris muris or Schistosoma mansoni—control and/or eradi-
cation of infection requires attack by eosinophils driven by
a predominant Th2 response [11]. Hosts (such as the AKR strain
of inbred mouse) that mount a predominantly Th1 response
involving interferon (IFN)–c go on to develop chronic infections
[12], and this IFN-c contributes towards a hyperplastic mucosal
pathology [13]. A Th2-mediated immune response promotes the
release of parasite-specific antibodies [7]. Interleukin (IL)–5 has
been shown to be involved in eosinophilia and goblet cell hy-
perplasia, whereas IL-13 and alternatively activated macrophages
are implicated in worm expulsion and anti-larval activity, with
involvement of basophils in the innate immune response to
infection [3, 14–16]. Mice with deletions in Toll-like receptor
(TLR) 4 or MyD88 become resistant to T. muris infection,
possibly because the expression of IFN-c induced by TLR sig-
naling mediates a Th1 response, which promotes subsequent
pathology [17]. There is growing evidence of the activity of
antimicrobial molecules in defense against other gut-tropic
pathogens and in modulation of the intestinal microbiota [3, 18–
21]. However, very little is known about the role of antimicrobial
peptides (AMPs) in control of helminth infections or of the impact
of colonisation by helminths on innate immune defenses. Lyso-
zyme does not play a role, but the Paneth cell product intelectin is
up-regulated in mice that go on to clear infection [22, 23].
With the growing evidence that AMP expression in the gut is
important in determining susceptibility to intestinal infection
and susceptibility to inflammatory disease [18–20, 24], we set
out to define and characterize the AMP expression profile in
chronic infection with Ascaris lumbricoides in human hosts. We
analyzed the mRNA expression of the genes for a2defensins,
b2defensins, and LL-37 in intestinal biopsy specimens, together
with cytokine and T cell subset transcription factor marker genes
both in the gut and in peripheral blood mononuclear cells
(PBMCs) by means of real-time reverse transcription poly-
merase chain reaction (RT-PCR).
MATERIALS AND METHODS
Study Setting
Study participants were recruited from Misisi township in
Lusaka, Zambia. This is an unplanned settlement south of
Lusaka with poor sanitation and inadequate hygiene facilities.
Adults (age,$18 years) were recruited for the study if they were
resident in a defined sector of Misisi and gave informed consent.
Potential participants were excluded if they were pregnant or
lactating, had experienced diarrhea #1 month before planned
participation, or had taken antibiotics or nonsteroidal anti-
inflammatory drugs in the same period. Prior work in this
population revealed that 17.4% of human immunodeficiency
virus (HIV)–negative adults were infected with A. lumbricoides,
compared with 13.1% of HIV-positive individuals [25]. Ethics
approval was obtained from the University of Zambia Research
Ethics Committee (007-10-07).
Determination of Helminth Infection and Treatment
All participants submitted 3 stool samples over 3–5-day periods
that were screened for the presence of eggs using the Kato-Katz
technique. If helminth infection was found, the persons were
designated as case patients, and they were designated as control
subjects if not. Depending on the parasite species detected,
infected participants were treated with albendazole (Zentel;
GSK; 400 mg twice daily for 3 days), praziquantel (Biltricide;
Bayer Pharmaceuticals Corporation; 400 mg/kg in 3 divided
doses on 1 day), and/or ivermectin (Stromectol; MSD; 9 mg
[200 lg/kg] as a single dose). Stool samples were collected
after treatment and checked for infection to confirm eradication
of worms. Ten mililiters of blood was collected prior to en-
doscopy to perform a complete blood cell count (including
eosinophil count), to determine HIV status, and to perform
a CD4 cell count if the subject was HIV seropositive, and serum
was separated and stored at -80C for cytokine enzyme-linked
immunosorbent assay (ELISA).
Biopsy Sample Collection and PBMC Isolation
Participants underwent enteroscopy with a fiberoptic entero-
scope (Olympus SIF-10) under sedation to collect biopsy sam-
ples of the jejunum, followed immediately by treatment
described above. An additional set of biopsies was performed
either 7 or 14 days after initiation of treatment. Samples were
immediately suspended in Tri Reagent (Sigma) and frozen
at -80C for RNA extraction. An additional 20 mL of venous
blood was collected prior to endoscopy in EDTA tubes (BD
Biosciences) before and after treatment. PBMCs were separated
using Ficoll-Paque Premium (GE Healthcare) and washed once
in phosphate-buffered saline (Sigma), and 1 3 107 cells were
resuspended in Tri Reagent (Sigma) and stored at -20C ready
for RNA extraction.
RNA Extraction and cDNA Preparation
RNA was extracted using the phenol-chloroform extraction
method, as described elsewhere [26]. In brief, all gut biopsy
samples were broken up using a mini-homogenizer and steril-
ized pestles and stored in fresh sterile molecular biology grade
(MBG) water (Sigma). RNA was subjected to DNase treatment
using RQ1 DNase (Promega, UK) in the presence of RNA
ribonuclease inhibitor (Promega). DNase-treated RNA was
then extracted using phenol-chloroform-isoamyl alcohol (ratio,
25:24:1; Sigma) and quantified by spectroscopy. cDNA was
prepared using standard protocols.
Quantitative Real-time RT- PCR
Primers for the CD41 T cell transcription factors RORct, T-bet,
GATA-3, and Foxp3 and the cytokines IFN-c, transforming
growth factor (TGF)–b, tumor necrosis factor (TNF)–a, IL-4,
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IL-5, and IL-10 were generated using Primer 3 software
(http://frodo.wi.mit.edu/primer3/input.htm) and synthesized
by Sigma. (For sequences, see http://www.icms.qmul.ac.uk/
Profiles/Digestive%20Diseases/Kelly%20Paul.htm.) GAPDH was
used as a reference standard for all PBMC cDNA, whereast CK-19
and GAPDH were used for gut cDNA. Quantitative real-time
PCR was performed using a Corbett Rotor Gene thermal cycler
and SYBR Green (Qiagen) detection over 45 cycles of 95C, 60C,
and 72C. cDNA from IL-1b–treated Caco-2 cells was used as
a positive control for all the gut RT-PCRs, whereas MBG water
was used as negative control (at least 3 in each run). HD5 and
HD6 were expressed as transcripts/lg total RNA using plasmid
standards, as previously described [20], but all other results were
expressed relative to GAPDH and/or CK-19.
Cytokine ELISAs
Aliquots of serum from case patients and control subjects that
had been stored at -80C for #6 months were used for mea-
surement of IFN-c, IL-13, IL-22, and TGF-b by ELISA (R&D
Systems) in accordance with the manufacturer’s instructions.
Data Analysis
Data analysis was performed using Stata software, version 10.1
(StataCorp), and GraphPad Prism, version 5.01 (GraphPad
Software). Nonparametric statistical tests were used because of
the nonnormal distribution of the data, which are summarized
below as median and interquartile range (IQR). The Fisher exact
test was used for proportions, the Kruskal-Wallis test was used
to compare distributions of unpaired data (case patients and
control subjects), and the Wilcoxon matched-pair rank sum test
was used to compare pre- and posttreatment values for the same
individual. Spearman’s rank correlation was used to determine
the correlation of peripheral blood and intestinal cytokine and
T cell subset markers.
RESULTS
Study Population in Misisi, Lusaka
We recruited 71 consenting individuals (age, 21–60 years). Case
patients were defined as those participants found to have
A. lumbricoides infection; coinfections with Strongyloides
stercoralis, S. mansoni, and Taenia saginata were also found
(Table 1). Case patients (n 5 27) and control subjects (n 5 44)
were similar with respect to age and HIV status, although more
women were found (P5 .002) with helminthiasis (Table 1), and
ownership of the house of residence showed clear evidence that
case patients were of lower economic status (P5 .03) (Table 1).
Table 1. Characteristics of the Study Population and Helminthiasis Diagnosis
Characteristic Infected Group Control Group P
n 27 44
Ratio of male to female subjects 3:24 20:24 .002a
Age, years
Mean 6 SD 38 6 11.2 38.8 6 11.1 NSb
Range 21–59 22–61
Ratio of HIV-positive to HIV-negative subjects (% of HIV-positive subjects) 10:17 (37) 15:29 (34.1) NSb
CD4 cell count in HIV-infected subjects, cells/lL
Mean6 SD 475 6 128.8 502 6 316 NSb
Range 247–671 242–1398
Eosinophil count, median (range) 0.2 (0.05–1310 9/l) 0.08 (0.04–0.72) .01310^9/lbb
Hemoglobin concentration, median g/dL (range) 13.3 (6.9–18.9) 14.35 (11.3–15.8) .02b
Infectious organism
Ascaris lumbricoides
No. of infected persons 27 0
Median egg count (range) 22,096 (168–63,840)
Strongyloides stercoralis, no. of infected persons 4 0
Schistosoma mansoni, no. of infected persons 1 0
Taenia saginata, no. of infected persons 1 0
Giardia intestinalis, no. of infected persons 0 0
Secondary education, no. of subjects 4 7 NSa
Ownership of house, no (%) of subjects 9 (33) 27 (61) .03
Estimated household income, kwacha 300,000 350,000 NSb
NOTE. HIV, human immunodeficiency virus; NS, not significant; SD, standard deviation.
a P value determined by the Fisher exact test.
b P value determined by the Kruskal-Wallis test.
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Case patients also had eosinophilia (P 5 .01) and lower
hemoglobin levels (P 5 .02). Stool samples examined after
treatment showed successful helminth eradication in all case
patients.
Gastrointestinal Expression of AMPs Differed in Case Patients
and Control Subjects
We characterized the gastrointestinal expression profiles in
jejunal biopsy samples from case patients and control subjects
using RT-PCR for mRNA of the a2defensins (HD5 and HD6),
the b2defensins hBD1 and hBD2, and the cathelicidin LL-37.
Biopsy samples were taken before treatment and at 7 (n 5 6) or
14 (n 5 21) days after treatment; there was no difference in the
changes in mRNA of HD5 and HD6 at 7 or 14 days, so these data
are considered together (Figures 1A and 1B). After treatment,
HD5 and HD6 expression did not change overall (Figure 1C
and 1D), but some variation was evident between individuals:
down-regulation of HD5 was observed in 60% of helminth-
infected individuals during infection, compared with posttreat-
ment values (Figure 1C), and in 48% of these subjects, we
observed down-regulation of HD6 expression (Figure 1D). Ex-
pression of HD5 was lower in biopsy samples taken from case
patients before (median, 1234; IQR, 286.6 - 6444) and after
(median, 1030; IQR, 276.1 - 14,045) treatment than in control
subjects (median, 8721; IQR, 646.7 - 56,384) (Figure 1E), but
expression of HD6 before (median, 43,353; IQR, 3048-405,461)
and after (median, 73,946; IQR, 8267-360,127) was higher
than in control subjects (median, 9210; IQR, 690.4 - 27,750)
(Figure 1F). hBD1 and LL-37 expression was lower in case pa-
tients, and there was no detectable mRNA of hBD2 in any biopsy
specimen obtained in this study (Table 2), even though mRNA
from IL-1b-treated Caco-2 cells gave a clear positive amplifica-
tion signal for hBD2 (data not shown). Expression of these an-
timicrobial peptide genes was completely unaffected by HIV
status (data not shown).
Gastrointestinal Expression of Th1 Phenotype Increased During
Helminth Infection
Wemeasured mRNA expression of CD41 T cell subset signature
transcription factors and cytokines in biopsy samples from the
infected group before and after treatment but from none of the
control subjects, because mRNA from intestinal tissue was
limited in quantity. There was a decrease in Th1 markers after
treatment, as reflected in IFN-c mRNA expression (observed in
72% of case patients; P 5 .009) and T-bet (in 88% of case
patients; P5 .01), suggesting that they were up-regulated during
infection. In quantitative terms, IFN-c mRNA relative to
GAPDH decreased following treatment (P 5 .009) and T-bet
mRNA decreased (P 5 .01, using the Wilcoxon rank sum test)
after treatment (Figure 2 A and 2B respectively). There was no
change in TNF-a or RORct expression (Figure 2 C and 2D,
respectively) nor in expression of GATA-3, Foxp3, TGF-b, IL-4,
IL-10, or IL-5 (data not shown).
Helminth InfectionWas Associated with Up-Regulated Peripheral
Blood Markers of All Major T cell Subsets and Some Cytokines
To compare the changes in the intestinal mucosa with the sys-
temic response, we looked at peripheral T cell signature tran-
scription factor mRNA expression in PBMCs from case patients
before and after treatment and from control subjects. There was
up-regulation of Th1 (P , .0001), Th2 (P 5 .04), Th17 (P ,
.0001), and Treg (P 5 .0002) markers in pretreatment case pa-
tients, compared with control subjects (Figure 3A), and altered
expression was observed in a range of cytokines: IFN-c (P5 .03)
and IL-10 (P 5 .002) were down-regulated, whereas IL-5 (P ,
.0001) and TGF-b (P , .0001) were up-regulated (Figure 3B).
Neither TNF-a nor IL-4 showed any changes (data not shown).
There was no change in subset markers after treatment (Figure
3A) or in any of the cytokines measured (IFN-c, IL-5, TGFb, and
IL-10 [Figure 3B]; data not shown for TNF-a and IL-4). Ex-
pression of these genes did not differ between HIV-infected and
HIV-uninfected case patients or control subjects.
Correlations Between Peripheral Blood T cell Subset Markers
and Cytokines
To explore the impact of ascariasis on these T cell markers and
cytokines, we looked for correlations between the markers
measured. Although the number of case patients and control
subjects is modest, some strong and significant positive corre-
lations were observed. Several correlations were seen only in
helminth infection and not in control subjects, some of which
are expected (such that between GATA-3 and Foxp3) and some
of which link apparently antagonistic subsets (such as T-bet and
IL-10 or IFN-c and IL-4) (see Supplementary Tables 1 and 2 at
https://docs.google.com/document/pub?id51k0m0bLjbJZGp-
plEhHNSldwXLMSoXLAM4OtLKsI7YjWI). Helminth infection
appears to abolish the correlation between GATA-3 and TNF-a
or and between Foxp3 and IL-4. None of the correlations were
seen exclusively as a consequence of HIV infection (see Sup-
plementary Tables 3 and 4, also at https://docs.google.com/
document/pub?id51k0m0bLjbJZGpplEhHNSldwXLMSoXLAM
4OtLKsI7YjWI).
HD5 Suppression During Helminth Infection Was Associated
With Peripheral Blood RORgt Expression
To explore the modulation of HD5 and HD6 expression during
infection, we dichotomized the cases into those with up-regula-
tion during expression (as inferred from changes following
eradication) and those with suppression, and we correlated this
change with mRNA of T cell subset markers in peripheral blood.
We found that HD5 suppression was significantly associated with
increased expression of RORct in PBMCs (Figure 4). The ex-
pression of Th1, Th2, and Treg markers was not associated with
this suppression, and changes in HD6 were not significantly as-
sociated with any of the markers used (Figure 4). There was no
significant association with any cytokinemRNA andHD5 or HD6
suppression, nor was it associated with HIV status.
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Figure 1. Differential expression of a-defensins in the intestinal mucosa during ascariasis. mRNA for HD5 and HD6 was quantified in jejunal biopsy
samples obtained from control subjects and from case patients before and after helminth eradication and are expressed as transcripts/lg of total RNA
extracted. A and B, expression of individual samples in multiple biopsy specimens taken after 7 or 14 days after treatment. C and D, changes following
treatment expressed as –fold change, relative to pretreatment values, such that values .1 represent an increase in expression and ,1 as a decrease
during infection. E and F, absolute mRNA quantities shown in case patients versus control subjects (represented as box whisker plots of median,
interquartile range, and range)
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Serum Cytokines Representative of Major T cell Subsets Were
All Down-Regulated in Helminth Infection and Did Not Explain
HD5 Suppression
To explore further the peripheral blood T cell responses, we
measured concentrations of 4 cytokines in serum that had been
chosen to be representative of the 4 major T cell subsets: IFN-c,
IL-13, IL-22, and TGF-b. IFN-c was not detected in most se-
rum specimens (data not shown). IL-13 and IL-22 concen-
trations were lower in case patients than in control subjects and
did not change after helminth eradication. IL-13 was detected
in all samples measured (in 35 control subjects and in 25 case
patients) but was lower in case patients (median, 91.4 pg/mL;
IQR, 82-142 pg/mL) than in control subjects (median, 220.3
pg/mL; IQR, 146.7-289.2 pg/mL; P , .0001) (Figure 5). IL-22
was detected in 16 control subjects (out of 30 samples) and 12
case patients (out of 27 samples) and was also lower (median,
0.04 pg/mL; IQR, 0.0-18.4 pg/mL) in case patients than in
control subjects (median, 22.4 pg/mL; IQR, 0.0-36.5 pg/mL;
P5 .001). TGF-b was detected in 15 control subjects (out of 35
samples) and in 13 case patients (out of 25 samples), but the
concentration did not differ between case patients (median, 0.0
pg/mL; IQR, 0.0-8.1 pg/mL) and control subjects (median, 0.0
pg/mL; IQR, 0.0-62.8 pg/mL) (Figure 5). There was no increase
Table 2. Ascariasis was Associated With Attenuated Expression
of hBD1 and LL-37
Group No. of subjects hBD1 hBD2 LL-37
Before treatment 27 NE NE 8
After treatment 27 NE NE 7
Control group 24 13a NE 21a
NOTE. hBD, human b2defensin; NE, no detectable mRNA expressed.
a P 5 .0001, determined by the Kruskal-Wallis test of differences between
control and pretreatment groups.
Figure 2. Association between helminth infection and increased expression of gastrointestinal CD41 Th1 phenotype markers. Jejunal biopsy samples
obtained before and after treatment were used to quantify, by real-time reverse-transcription polymerase chain reaction, the expression of interferon
(IFN)–c (A), T-bet (B), tumor necrosis factor (TNF)–a (C), and RORct (D) represented as box whisker plots of median, interquartile, and range. mRNA
expression is shown relative to GAPDH
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after treatment and no computed association between
HD5 suppression and concentrations of IL-13, IL-22, or
TGF-b.
DISCUSSION
We have previously shown that helminth infection (particularly
ascariasis) is common in this population [25], but the effects of
helminth infection on innate defense mechanisms in the
intestinal mucosa are, to our knowledge, unknown. Our finding
that helminthiasis is associated with lower expression of HD5,
hBD1, and LL-37 might explain some of the previously noted
reduction in HD5 expression in this population [26] but not
the reduction in HD6. However, this would only be true if
exposure to helminths causes the change in HD5 expression
and not if low HD5 expression predisposes to helminthiasis.
To our knowledge, there are no data on the effect of human
antimicrobial peptides on nematode development. In general,
Figure 4. Association between HD5 suppression and increased expression of RORct during infection. The study group was dichotomized into those
with up-regulation of HD5 or HD6 during helminth infection and those with down-regulation of HD5 or HD6. mRNA of CD41 T cell subset markers, mean
expression ratio to GAPDH, in peripheral blood mononuclear cells is shown in relation to the changes in gastrointestinal expression of HD5 and HD6
expression. Asterisks represent statistical significance. *P 5 .01.
Figure 3. Association between helminth infection and altered peripheral expression of CD41 T subset markers and cytokines. Peripheral blood
mononuclear cells were isolated from blood from control subjects and case patients before and after treatment, and real time reverse-transcription
polymerase chain reaction was performed; mRNA expression is shown relative to GAPDH for CD41 T subset markers (Figure 3A) and cytokines (Figure 3B)
and represented as box whisker plots of median, interquartile range, and range.
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the lower antimicrobial peptide expression in case patients
(higher expression in the case of HD6) did not change sig-
nificantly after treatment, which could be explained either if
lower defensin expression predisposes to helminthiasis or if
14 days is insufficient for such changes to occur. We did not
examine antimicrobial peptide expression after 14 days, because
intercurrent intestinal infections, to which adults in this com-
munity are exposed [25], might complicate interpretation of
immunological changes during convalescence. Therefore, we
cannot distinguish between these possibilities, and we propose
that the only way to resolve the issue of causation is to study
experimental helminth infection in naive volunteers.
Our data indicate that the dominant T helper phenotype in
control subjects was Th2 but that, in case patients, a Th1 subset
was more prominent during infection. In animal studies,
a dominant Th2 response is associated with clearance of hel-
minth infection, but a dominant Th1 response is associated with
persistent infection [11]. Our data are therefore consistent with
the hypothesis that persistent gut helminthiasis in humans is at
least partly a failure of the Th2 response. This also correlates
with observations that a predominant Th2 phenotype (with it-
s associated cytokines) in humans confers immunity to
reinfection and/or immunity [7, 27, 28]. Proinflammatory
cytokines can suppress defensin expression [29], which would fit
with Th1- or Th17-mediated defensin suppression in helmin-
thiasis when the Th2 response is attenuated.
Recent work done by Salzman et al [21] suggests that HD5
expression regulates IL-17A production by Th17 cells in the
small intestine. Helminth infection has been shown not to
induce the expression of IL-22 in the liver [30]. However, IL-22
has been reported to be involved in the immune response to
other infections in the gut mucosa, so it is interesting to spec-
ulate that helminth-mediated immunomodulation might alter
host susceptibility to those bacterial infections against which IL-
22 is protective [31]. Helminth infection was associated with
reduced concentrations of IL-22 in serum, so clearly more work
needs to be done to understand the effect of helminth infections
on Th17 responses. These interactions are also complicated by
Figure 5. Serum cytokine concentrations in helminth infection. Serum concentrations of 4 cytokines, selected to represent major T cell subsets
(interferon [IFN]–c, interleukin [IL]–13, IL-22, and transforming growth factor [TGF]–b), were measured by enzyme-linked immunosorbent assay in
samples from control subjects and in pretreatment or posttreatment samples from case patients (represented as box whisker plots of median,
interquartile range, and range). Asterisks represent statistical significance for Kruskal-Wallis test of differences. ***P , .0001; **P 5 .001.
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the fact that RORct expression in the intestine is not entirely
restricted to the CD41 Th17 phenotype and that there are other
immune cells that also express RORct and possibly secrete IL-22
[32, 33].
It is not known how the presence of luminal helminths is
sensed by the immune system. Ascarid worms occupy a purely
luminal niche, and there is no attachment or invasion within the
mucosa, unlike adult hookworms or Strongyloides species, which
have a more obvious point of contact with host immune sensory
elements. However, the jejunum is the primary site for larval
localisation [34]. It is also likely that soluble antigens shed by the
worms could be sensed by inductive sites in Peyer’s patches if
there are receptors that can distinguish them from food- or
microbiota-derived antigens. Helminth-derived glycans are
involved in the activation of various antigen presenting cells
(reviewed in [35]).The dissociation between posttreatment CD41
T cell subset phenotypes and cytokine expression in gut and
peripheral blood might suggest the presence of long-lasting cir-
culating antigens that could possibly circulate for long periods of
time [36].
We were surprised about the predominance of women in the
case patients. We have previously noted an under-representation
of younger men in the Misisi cohort but we would expect this to
apply to case patients and control subjects equally. The rate of
house ownership, one measure of economic status, was signifi-
cantly lower among case patients. We found no influence of HIV
infection on antimicrobial peptide expression, which is entirely
consistent with our previous observations in this population [20,
37]. We were somewhat surprised that we could detect no effect
of HIV on mRNA of T cell subsets or the cytokines we tested. In
the case of mucosal expression of these genes, we did not have
sufficient mRNA to quantify the mRNA in control subjects, so it
may be that helminth infection overrides any effect of HIV. In
PBMCs, there was clearly no effect of HIV in either case patients
or control subjects, but the number of control subjects was small.
We believe that our data showing modulation of AMP gene
expression are the first data of this kind in humans. There were
surprisingly few changes in AMP expression following eradica-
tion, at least within the time scale of our study. The effect of
Th17 cells that are implied by our observations about RORct are
intriguing and deserve future exploration. It would be useful in
future studies to characterize T cell subsets by flow cytometry,
but even very detailed characterization will not answer the
fundamental question that our study raises, which is whether the
changes we observed are a consequence of helminth infection or
in some way predispose to it. This question can probably only be
answered by challenge studies in human volunteers.
Supplementary Data
Supplementary data are available at http://jid.oxfordjournals.org
online.
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